At COREX, we deliver potentially lifesaving treatments to patients worldwide through the ‘Named Patient Programme’.
In different countries such programmes have different names — Expanded Access in the US and Special Access Scheme in Canada. The UK uses EAMS — Early Access Medicines Schemes, known as Compassionate Use in Germany — whatever the variation on the title, they all mean the same thing. Hope.
Our expert team handles all regulatory issues with in-depth knowledge and invaluable local insight
From import licence submission, through customs clearance, spe- cialist transportation through to distribution, COREX takes care of the supply chain from start to finish.
More than a thousand patients have received vital medications for the treatment of diseases.
PREPARATION OF DOCUMENTATIONfor obtaining an import license in accordance with the relevant regulatory requirements.
OBTAINING PERMIT FOR IMPORTATION IN A TIMELY MANNER
EXPEDITING CUSTOMS CLEARANCE
DELIVERY OF THE DRUG IN COMPLIANCEwith required temperature regime.
We work directly with trusted manufacturers and authorized distributors.
All processes carried out in temperature controlled and secure warehouse facilities.
In accordance with GxP standards.
Return, disposal and destruction of investigational products from clinical trials during and at the end of studies.
We manage returns and carry out certified destruction of drugs and materials during and at the conclusion of clinical studies.
Secure storage of all medicinal products in our network of warehouses in all temperature regimes.
We work with Clinical Trial Organisations and Healthcare Providers to access and supply potentially life-changing medicines and treatments, and provide practical care and supporting patients and families with tailored solutions.
We’re here to help.
Email us at email@example.com or use our feedback form to send us your question.